Board Member
TransMedics Group, Inc. (TMDX)Equibles does not estimate personal net worth.
Get an email with a short summary when TransMedics Group, Inc. publishes a filing, an earnings call transcript or a press release.
Get TMDX alertsWaleed Hassanein is recorded as CEO and Board Member at TransMedics Group, Inc. (TMDX). The newest filing on record that lists Waleed Hassanein as CEO and Board Member at TransMedics Group, Inc. (TMDX) is dated April 10, 2026. The proxy statement of TransMedics Group, Inc. reports total compensation of $10,915,533 for Waleed Hassanein in fiscal 2025, including a base salary of $776,923. Disclosed compensation is on record for 8 fiscal years. Waleed Hassanein has spoken on 25 earnings calls and 3 other investor events across 1 company, most recently for TransMedics Group, Inc. on September 14, 2026. TransMedics Group, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TransMedics Group, Inc. includes Fernando Araujo (CFO), Gerardo Hernandez (CFO), Anil Ranganath (General Counsel) and 7 others.
“These are going to be a little bit more than a couple of slides because I felt it's important to kind of cover a few important topics. This is our forward-looking statement.”
“These are going to be a little bit more than a couple of slides because I felt it's important to kind of cover a few important topics. This is our forward-looking statement.”
“Ryan, we're grateful for the opportunity to be here in Chicago beautiful city of Chicago this is our disclosure slide to remind you transmedics is in this very unique very exciting very inspiring field of organ transplantation it's a niche market that we happen and privileged to be the one created the area of that…”
“Good afternoon, everyone, and welcome to Transmedic's first quarter's 2026 earnings As always, joining me today is Gerardo Hernandez, our Chief Financial Officer.”
“Good afternoon, everyone, and welcome to TransMedics' Fourth Quarter and Full Year 2025 Earnings Call. Joining me today is Gerardo Hernandez, our Chief Financial Officer.”
Start not stated–present
Last confirmed April 10, 2026
Start not stated–present
Last confirmed April 10, 2026
Medical Devices · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $776,923 | $10,915,533 |
| 2024 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $688,462 | $8,199,136 |
| 2023 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $633,846 | $6,758,070 |
| 2022 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $575,192 | $3,287,862 |
| 2021 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $535,000 | $7,370,365 |
| 2020 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $533,627 | $2,385,687 |
| 2019 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $448,615 | $3,159,298 |
| 2018 | TransMedics Group, Inc. (TMDX) | President and Chief Executive Officer | $384,000 | $524,000 |
